An AI-engineered peptidyl fluorescence probe for GRP78: advancing renal cell carcinoma diagnosis

Abstract

By the integration of AI and molecular engineering, we developed an activatable peptidyl fluorescent probe targeting GRP78 with high sensitivity and specificity. The probe enabled high-contrast imaging of renal cell carcinoma in patient-derived tissue samples. AI-driven molecular engineering provides a scalable platform for developing precision diagnostics.

Graphical abstract: An AI-engineered peptidyl fluorescence probe for GRP78: advancing renal cell carcinoma diagnosis

Supplementary files

Article information

Article type
Communication
Submitted
11 Sep 2025
Accepted
30 Nov 2025
First published
08 Dec 2025

Chem. Commun., 2026, Advance Article

An AI-engineered peptidyl fluorescence probe for GRP78: advancing renal cell carcinoma diagnosis

L. Zhang, K. An, Z. Yang, M. Yang, H. Guo, Y. Jia, K. Liu, X. Liang and C. Hu, Chem. Commun., 2026, Advance Article , DOI: 10.1039/D5CC05238F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements